Aqualumos

Aqualumos is developing photocatalysis based technologies that break down toxic PFAS and eliminate them from the ecosystem. Aqualumos is developing an integrative system for water utilities and manufacturers to cost effectively remediate PFAS and meet regulatory requirements.

Company Overview

Avitus™ Orthopaedics

Avitus™ Orthopaedics, Inc. was established in 2011 with the mission of developing new orthopaedic technologies that improve clinical outcomes while decreasing health care costs. The company is developing a novel surgical device that will enable surgeons to use autologous bone graft material to improve the lives of patients. Avitus is currently looking to close their Series A round.

Company Overview

Bastion Health

Bastion Health is a digital health platform pioneering technology to impact and enhance male reproductive health and prostate health. Found on the belief that healthcare should be accessible, affordable, and comprehensive, Bastion created at-home testing kits for men. 

Company Overview

Biorasis

Biorasis, Inc. is a privately held company committed to developing a wireless, needle-implantable (0.5 x 0.5 x 5 mm) biosensor platform for real time, continuous metabolite monitoring. Based at UConn's Technology Incubation Program, Biorasis is a faculty-owned startup.

Company Overview

Cornovus Pharmaceuticals

Cornovus Pharmaceuticals, Inc. commenced operations in October of 2011. The company is focused on the development of a novel cardioprotective compound, MRS2339, for the treatment of heart failure. MRS2339 is a small molecule that stimulates cardiac myocyte P2X4 receptors, which in turn increases myocyte eNOS and cGMP. The compound has been shown effective in multiple preclinical models of heart failure and currently is progressing through IND enabling studies.

Company Overview

Dashride

Dashride is the leading provider of mobile dispatching software for transportation companies, supporting nearly 500 transportation companies in most major U.S. cities, the United Kingdom, Singapore, and Australia. The comprehensive software grew out of Sobrio, a sober rides company that won UConn’s Business Plan Competition and the School of Business’ first Innovation Quest competition when its founders were students.

Company Overview

Eascra Biotech

Based on DNA nanotechnology, our novel family of Janus base nano-materials provides highly effective, super biocompatible solutions that enable enhanced therapeutic delivery and regenerative medicine for articular cartilage, central nervous system disorders, solid tumors, and other chronic conditions. Our three generations of DNA-inspired nanotubes are a cost-effective alternative to existing options, and they have excellent scalability. We can customize our Janus base nanotechnologies to enhance the therapeutic efficacy of drug treatments for a variety of chronic conditions and medical needs.

Company Overview

Eir Medical Devices

Eir Medical Devices developed a device designed to help physicians measure patients’ blood viscosity, a traditionally unused, but promising indicator of cardiac risk and health for patients on dialysis and certain types of cancers.

Company Overview

Encapsulate

Encapsulate BioChip technology grows patient-derived cancer cells ex vivo, and screens them against chemotherapeutic drugs. With this technology the oncologist can choose the most effective chemotherapy drug prior to treatment on an individualized basis.

Company Overview

Enviro Power

Enviro Power is a Connecticut-based company bringing to market heating equipment that provides high-efficiency heat and generates low-cost electricity. Called SmartWatt, it gives building owners and homeowners the ability to lower both their heating and electricity costs with something every home and building needs anyway – heating equipment.

Company Overview

Genesist

Genesist with the help of evolutionary biology empowers the local and healthy cells around a cancerous tumor to stop cancer from metastasis and invasion. A CRISPR-based therapy to make stromal cells more resistant to cancer.

Company Overview

Hans Health

Hans Health's platform technology, known as a Genomics Driven Immunoproteomics or GDI, allows rapid identification of personalized tumor mutation profiles that are recognized by cancer patients’ own immune system. This new immune assessment tool has the potential to offer more effective treatment options for some of the most aggressive cancer cases.

Company Overview

LambdaVision

LambdaVision, Inc. (LVI) is developing a high-resolution, protein-based retinal implant to restore vision to the millions of patients blinded by retinal degenerative diseases, including retinitis pigmentosa (RP) and age-related macular degeneration (AMD). Based on a UConn chemistry discovery, the patent-protected retinal implant technology developed by LambdaVision uses the light-activated protein, bacteriorhodopsin, to replace the function of the damaged photoreceptor cells. The flexible, subretinal implant is powered by incident light and does not require any external power supplies or bulky hardware on or outside the eye, and offers the potential for far greater resolution than competing electrode-based technologies. LambdaVision, whose CEO is a UConn alumna, is currently at the pre-seed stage, but is looking for seed money to support further preclinical development.

Company Overview

Land Maverick

Land Maverick provides autonomous robots, MAVs, that collect hundreds of data points on temperature, moisture, and pH of the soil to help golf courses better make decisions about applying fungicide and other chemicals to soil.

Company Overview

Levo International

Christian Heiden is a senior at the University of Connecticut majoring in Agricultural and Resource Economics. Heiden started Levo after traveling to Haiti where he saw both the depth and scope of the food security challenges in that country and the real possibilities for solutions. Christian incorporated his organization, Levo International in 2017, when when he was a freshman. Levo’s mission is to deliver food security solutions and leverages those solutions to strengthen communities across the globe. They innovate in hydroponic farming methods, simplifying technology and maximizing impact through community partnership. Recognizing the innate human ability to solve problems, Levo combines that ability with a distributed, sustainable approach to empower individuals to strengthen their own communities.

Company Overview

Lipid Genomics

Lipid Genomics is developing its FDA-approved investigational drug targeted at people with variations in the HDL ("good cholesterol") SCARB1 gene. More than 117 million people in the U.S. could benefit from this drug. Lipid Genomics has a potential to generate a very sizable profit as the market size for this therapeutic is $2.8 billion and the market size for their second product, novel immune checkpoint inhibitor lymphocyte activation gene-3 (LAG-3), is $1.4 billion.

Company Overview

PatentPlus AI

PatentPlus is an AI-driven patent search engine that helps achieve fast and accurate patentability determinations. The platform creates more thorough invention disclosures, fully capturing an invention's novel and inventive features. The generated data is then used to perform automated technical prior art analysis.

Company Overview

PiezoBioMembrane

PiezoBioMembrane, Inc. was registered on Nov 05, 2021 as a stock type company located at c/o Department of Mechanical Engineering, UCONN.

Company Overview

Pisces Atlantic

Pisces Atlantic develops and manufactures novel fish feeds made from vegetable and insect proteins. It offers consultations for each customer, allowing those who farm niche species, or who are new to the aquaculture industry to learn from their experience with fish feeds and places orders for custom formulations.

Company Overview

Phoenix Tailings

Phoenix Tailings turns a liability into an asset by recycling and re-mining hazardous mining waste (tailings) from the metals industry to creating valuable raw metals at a fraction of the cost. Phoenix Tailings was founded with the mission to make truly sustainable mining possible, by making it profitable for everyone.

Company Overview

Potentiometric Probes

Potentiometric Probes develops voltage-sensitive dye (VSD) technology for neuroscience and cardiac research. The company’s founders have a long history of developing VSDs and invented early classic VSDs such as Di-4-ANEPPS. But much has changed since the introduction of Di-4-ANEPPS (details below) and Potentiometric Probes is focused on providing researchers the best VSDs on the market in terms of signal-to-noise ratio, speed, stability, toxicity, among other factors.

Company Overview

SedMed

SedMed is a mobility products company that improves the safety & independence of those who struggle with Activities of Daily Living and reduces injuries to health care workers.

Company Overview

Shoreline Biome

Shoreline Biome's all-in-one, easy-to-use microbiome assay kits are the solution for researchers at all levels seeking complete, high-quality microbiome assay data sets. Our kits are fast, complete, and uncomplicated systems designed to transform your complex samples from lysis to sequencing to analysis with precision barcoded results.

Company Overview

Stemify

Stemify is the World's only STEM focused learning platform.The Stemify platform offers a full library of instructional STEM focused videos and placement assessment for pre-algebra through calculus. Specific features of the product include practice and placement assessments for all STEM topics, embedded quizzes within the videos, and most importantly, personalized student study plans tailored specifically to each student based on their assessments and progress through the instructional content and quizzes.

Company Overview

Thetis Pharmaceuticals

Thetis Pharmaceuticals LLC is developing novel drugs to treat inflammation-related gastrointestinal diseases with high unmet medical needs. The lead candidate, TP-252, is rapidly advancing through pre-clinical evaluations with the goal of beginning clinical FDA studies in 2018. Thetis aims to partner with a large pharmaceutical company to bring TP-252 to market by 2023.

Company Overview

Torigen Pharmaceuticals

Torigen Pharmaceuticals, Inc. has developed a treatment that can work for multiple tumor indications, treating more than 2 million companion animals diagnosed with cancer each year. Its product, VetiVax, is a novel, personalized immunotherapy that uses the animals’ own tumor cells to fight cancer. When combined with an innovative bulking agent, MIMTM (Matrix Immune Modulator), an overall reduction in tumor size and inhibition of metastasis have been noted. The treatment has been proven safe in a Phase I trial.

Company Overview

VoltXon Inc

VoltXon Inc. created a new energy harvesting/sensing technology with outstanding power output and sensing capabilities with applications in smart city, autonomous electric vehicles, and others.

Company Overview

Voxion

Voxion, Inc. is a voice technology company, making interactive content for Alexa and the Google Assistant. Voxion connects your phone to your smart speaker to provide visually engaging party games that you can share with friends and family.

Company Overview

Webquity

Webquity aims to make online education an equitable playing field by providing universal accessibility software to differently-abled users. This is done through a personalized evaluation that identifies and addresses a student's learning needs.

Company Overview

YouComm

YouComm is a tablet-based platform that allows a patient to choose their problem or need from a list or write a custom message that will be sent via text message directly to their caregiver. YouComm incorporates head-movement tracking and voice recognition technology for patients who are immobile.

Company Overview